Esperion Therapeutics, Inc. (0IIM.L)
USD 2.27
(-8.85%)
USD 2.27
(-8.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 116.33 Million | 75.47 Million | 78.44 Million | 227.54 Million | 148.36 Million | 184.47 Million |
| Cost of Revenue | 43.26 Million | 26.96 Million | 14.21 Million | 2.39 Million | 175.61 Million | 265 Thousand |
| Gross Profit | 73.06 Million | 48.5 Million | 64.23 Million | 225.15 Million | -27.24 Million | 184.2 Million |
| Operating Expenses | 271.89 Million | 228 Million | 290.96 Million | 346.55 Million | 241.46 Million | 204.58 Million |
| Selling, General and Administrative Expenses | 142.52 Million | 109.08 Million | 184.98 Million | 199.61 Million | 65.85 Million | 33.09 Million |
| Research and Development Expenses | 86.1 Million | 118.92 Million | 105.97 Million | 146.93 Million | 175.61 Million | 171.48 Million |
| Other Expenses | - | 2.65 Million | 3.97 Million | 515 Thousand | 4.05 Million | 2.77 Million |
| Cost and Expenses | 271.89 Million | 254.97 Million | 305.17 Million | 348.94 Million | 241.46 Million | 204.58 Million |
| Operating Income | -155.56 Million | -179.5 Million | -226.73 Million | -121.39 Million | -93.1 Million | -204.58 Million |
| Interest Expense | 58.97 Million | 56.81 Million | 46.35 Million | 22.67 Million | 8.12 Million | 100 Thousand |
| Income Tax Expense | - | 54.15 Million | 49.71 Million | 22.63 Million | 11.85 Million | 2.87 Million |
| Earnings before Tax | -209.24 Million | -233.65 Million | -269.1 Million | -143.55 Million | -97.16 Million | -201.81 Million |
| Net Income | -209.24 Million | -287.81 Million | -318.82 Million | -166.18 Million | -109.02 Million | -201.81 Million |
| Earnings Per Share Basic | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 |
| Earnings Per Share Diluted | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 |
| Weighted Average Shares Outstanding | 103.1 Million | 66.4 Million | 28.9 Million | 27.47 Million | 27.09 Million | 26.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 103.1 Million | 66.4 Million | 28.9 Million | 27.47 Million | 27.09 Million | 26.75 Million |
| Gross Margin | 0.63 | 0.64 | 0.82 | 0.99 | -0.18 | 1.00 |
| EBIT Margin | -1.29 | -2.34 | -2.84 | -0.53 | -0.60 | -1.11 |
| Profit Margin | -1.80 | -3.81 | -4.06 | -0.73 | -0.73 | -1.09 |
| EBITDA | -150.1 Million | -176.34 Million | -222.14 Million | -120.33 Million | -88.72 Million | -204.32 Million |
| Earnings Before Tax Margin | -1.34 | -2.38 | -2.89 | -0.53 | -0.63 | -1.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 73.83 Million | 137.73 Million | 32.25 Million | 116.33 Million | 33.96 Million | 25.78 Million |
| Cost of Revenue | 15.61 Million | 10.07 Million | 11.45 Million | 43.43 Million | 13.37 Million | 6.78 Million |
| Gross Profit | 58.21 Million | 127.66 Million | 20.79 Million | 72.9 Million | 20.59 Million | 19 Million |
| Operating Expenses | 55.63 Million | 65.46 Million | 63.15 Million | 228.46 Million | 61.5 Million | 62.84 Million |
| Selling, General and Administrative Expenses | 44.17 Million | 41.98 Million | 45.41 Million | - | 33.24 Million | 33.95 Million |
| Research and Development Expenses | 11.46 Million | 13.4 Million | 17.74 Million | - | 14.88 Million | 22.09 Million |
| Other Expenses | 2.45 Million | 10.07 Million | 1.08 Million | 5.29 Million | 13.37 Million | 6.78 Million |
| Cost and Expenses | 71.25 Million | 65.46 Million | 74.61 Million | 271.89 Million | 61.5 Million | 62.84 Million |
| Operating Income | 2.57 Million | 72.26 Million | -42.36 Million | -155.56 Million | -27.53 Million | -37.05 Million |
| Interest Expense | 13.72 Million | -14.02 Million | 15.05 Million | 58.97 Million | -14.99 Million | -14.53 Million |
| Income Tax Expense | - | -41 Thousand | -27.42 Million | -3895.00 | -26 Thousand | -51 Thousand |
| Earnings before Tax | -61.92 Million | 61.02 Million | -56.34 Million | -209.24 Million | -41.25 Million | -49.93 Million |
| Net Income | -61.92 Million | 61.02 Million | -56.34 Million | -209.24 Million | -41.25 Million | -49.93 Million |
| Earnings Per Share Basic | -0.33 | 0.36 | -0.50 | - | -0.37 | -0.46 |
| Earnings Per Share Diluted | -0.33 | 0.32 | -0.50 | - | -0.37 | -0.46 |
| Weighted Average Shares Outstanding | 188.79 Million | 169.25 Million | 112.4 Million | 103.1 Million | 111.86 Million | 109.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 188.79 Million | 189.64 Million | 112.4 Million | 103.1 Million | 111.86 Million | 109.24 Million |
| Gross Margin | 0.79 | 0.93 | 0.64 | 0.63 | 0.61 | 0.74 |
| EBIT Margin | 0.04 | 0.52 | -1.31 | - | -0.81 | -1.44 |
| Profit Margin | -0.84 | 0.44 | -1.75 | -1.80 | -1.21 | -1.94 |
| EBITDA | 2.58 Million | 72.26 Million | -42.36 Million | - | -27.53 Million | -37.05 Million |
| Earnings Before Tax Margin | 0.03 | 0.52 | -1.31 | -1.34 | -0.81 | -1.44 |
2370
JGHG
0QQN
VIRI
BRKA
0KGB